LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 1 von insgesamt 1

Suchoptionen

Artikel: Rhabdomyolysis and renal failure associated with gemfibrozil monotherapy.

Layne, Richard D / Sehbai, Aasim S / Stark, Linda J

The Annals of pharmacotherapy

2004  Band 38, Heft 2, Seite(n) 232–234

Abstract: Objective: To report a case of rhabdomyolysis and acute renal failure associated with gemfibrozil monotherapy of hyperlipidemia.: Case summary: A 30-year-old white man with hypertension, type 1 diabetes mellitus, and hyperlipidemia was hospitalized ... ...

Abstract Objective: To report a case of rhabdomyolysis and acute renal failure associated with gemfibrozil monotherapy of hyperlipidemia.
Case summary: A 30-year-old white man with hypertension, type 1 diabetes mellitus, and hyperlipidemia was hospitalized due to myalgias, nausea, and vomiting that began after he started working as a jackhammer operator 4 days previously. His medications were lisinopril, aspirin, insulin, and gemfibrozil. Creatine kinase and creatinine, which previously had been mildly elevated and normal, respectively, were markedly elevated, consistent with rhabdomyolysis with acute renal failure.
Discussion: As of December 8, 2003, this is the only report of a patient with normal baseline creatinine level who developed rhabdomyolysis with acute renal failure associated with gemfibrozil monotherapy. Strenuous exertion, hypovolemia, and lisinopril use may have contributed to the severity of illness. An objective causality assessment revealed that an adverse drug reaction to gemfibrozil was possible.
Conclusions: Gemfibrozil monotherapy of hyperlipidemia may predispose to rhabdomyolysis with acute renal failure. Patients using gemfibrozil should be cautioned regarding strenuous exertion, dehydration, and the need for prompt evaluation of myalgias.
Mesh-Begriff(e) Acute Kidney Injury/chemically induced ; Adult ; Creatinine/blood ; Diabetes Mellitus, Type 1/complications ; Gemfibrozil/adverse effects ; Humans ; Hyperlipidemias/complications ; Hyperlipidemias/drug therapy ; Hypertension/complications ; Hypolipidemic Agents/adverse effects ; Male ; Physical Exertion ; Rhabdomyolysis/chemically induced ; Rhabdomyolysis/physiopathology
Chemische Substanzen Hypolipidemic Agents ; Creatinine (AYI8EX34EU) ; Gemfibrozil (Q8X02027X3)
Sprache Englisch
Erscheinungsdatum 2004-02
Erscheinungsland United States
Dokumenttyp Case Reports ; Journal Article
ZDB-ID 1101370-9
ISSN 1542-6270 ; 1060-0280
ISSN (online) 1542-6270
ISSN 1060-0280
DOI 10.1345/aph.1D282
Signatur
Zs.A 900: Hefte anzeigen Standort:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Kategorien

Zum Seitenanfang